Casey L Bales

5PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro

|Jun 03, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.

Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger

|Jan 05, 2022
The impact of SBF2 on taxane-induced peripheral neuropathy.

Geneva M Cunningham, Fei Shen, Xi Wu

|Dec 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger

Pageof 1